National Cancer Institute - IMAT

Success Stories

Gary Latham, Ph.D.
Ambion/Asuragen


  • IMAT Award: Enzymatic Tools for Degrading Tissue and Preserving RNA (2001)
  • Current SBIR Phase II Awardee (2005-2007)
  • Impact: Flexible handling of tissue samples while maintaining high performance gene expression analysis
  • Patent Pending (application serial number 60/514,313)
  • Commercially released by Ambion in February, 2005
Microproteomic Profiling in FFPE Tissue
Microproteomic Profiling in FFPE Tissue

Back To TopBack to Top
Skip Navigation